Kempen & Co logo

Kempen & Co

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

Kempen & Co is a Dutch merchant bank providing financial services in asset management, securities broking and corporate finance.

Investor Profile

Kempen & Co has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Biopharma, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (50%)
  • Series B (50%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kempen & Co frequently co-invest with?

MedSciences Capital
Europe, Zuid-Holland, The Netherlands, The Hague
Co-Investments: 1
Jefferies
North America, New York, United States, New York
Co-Investments: 1
MP Healthcare Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
KS
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

What are some of recent deals done by Kempen & Co?

Ablynx

Zwijnaarde, Oost-Vlaanderen, Belgium

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJun 30, 2014
Amount Raised: $57,099,509
Pronota

Ghent, Oost-Vlaanderen, Belgium

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

BiotechnologyHealth CareHealth Diagnostics
Series BMay 19, 2010
Amount Raised: $1,852,552